# Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin

> **NCT07307677** · NA · RECRUITING · sponsor: **Mst.Sumyara Khatun** · enrollment: 60 (estimated)

## Conditions studied

- PCOS(Insulin Resistant)

## Interventions

- **DRUG:** Metformin 500mg
- **COMBINATION_PRODUCT:** Melatonin 3mg

## Key facts

- **NCT ID:** NCT07307677
- **Lead sponsor:** Mst.Sumyara Khatun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-11
- **Primary completion:** 2026-03-10
- **Final completion:** 2026-08-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07307677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07307677, "Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07307677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*